Natalie J. Thornburg

Centers for Disease Control and Prevention — United States

Medicine · Health Sciences

54h-index24.2kcitations208works11.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(136), SARS-CoV-2 detection and testing(78), COVID-19 Clinical Research Studies(67), Respiratory viral infections research(41), COVID-19 epidemiological studies(37)

Publications201 total

Optimizing the sensitivity of detection of respiratory syncytial virus infections in longitudinal studies using the combination of weekly sample testing and biannual serology
American Journal of Epidemiology·2025Open Access
Optimizing the sensitivity of detection of respiratory syncytial virus infections in longitudinal studies using the combination of weekly sample testing and biannual serology
2025Open Access
Evolutionary dynamics of Respiratory Syncytial Virus in pre-pandemic, pandemic, and post-pandemic periods in Houston, Texas, USA
2025Open Access
Corrigendum to Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
Journal of Clinical Investigation·2025Open Access
Integrating genomic data into test-negative designs for estimating lineage-specific COVID-19 vaccine effectiveness
2025· 2 citedOpen Access
Comparative analysis of environmental persistence of SARS-CoV-2 variants and seasonal coronaviruses
Applied and Environmental Microbiology·2025· 2 citedOpen Access
In Vitro Study Comparing SARS-CoV-2 Ancestral and Omicron Lineages Sequence & Neutralization Differences
International Journal of Infectious Diseases·2025Open Access
Association of infection-induced antibody levels with risk of subsequent SARS–COV-2 reinfection among healthcare professionals, Rhode Island, 1 March 2020–17 February 2021
Microbiology Spectrum·2025Open Access
P-710. Epidemiology of RSV infections in a birth cohort of healthy children, PREVAIL Cohort 2017-2020
Open Forum Infectious Diseases·2025Open Access
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
JAMA Pediatrics·2024· 43 citedOpen Access
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024
MMWR Morbidity and Mortality Weekly Report·2024· 44 citedOpen Access
Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism
The Journal of Infectious Diseases·2024Open Access
Salivary immune responses after COVID-19 vaccination
PLoS ONE·2024Open Access
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity—IVY Network, 26 Hospitals, 18 October 2023–9 March 2024
Clinical Infectious Diseases·2024· 40 citedOpen Access
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024
2024· 7 citedOpen Access
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves
Vaccines·2024· 4 citedOpen Access
Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents—Georgia, October 2020–July 2022
PLoS ONE·2024· 4 citedOpen Access
Endemic Coronavirus Infections are Associated with Strong Homotypic Immunity in a US Cohort of Children from Birth to 4 Years
Journal of the Pediatric Infectious Diseases Society·2024· 3 citedOpen Access
Factors Associated With Prolonged Respiratory Virus Detection From Polymerase Chain Reaction of Nasal Specimens Collected Longitudinally in Healthy Children in a US Birth Cohort
Journal of the Pediatric Infectious Diseases Society·2024· 18 citedOpen Access
Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel
Access Microbiology·2024· 3 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Azaibi Tamin(15), Jennifer L. Harcourt(15), Sandra Lester(15), Lisa Mills(13), Aron J. Hall(12), Brandi Freeman(11), Jacqueline E. Tate(9), H. Keipp Talbot(8), Susan I. Gerber(7), Alicia M. Fry(7), Brett Whitaker(7), Wesley H. Self(7), Ian W. Pray(7), Angela Dunn(6), Jarad Schiffer(6), Natasha Halasa(6), Carlos G. Grijalva(6), Ryan P. Westergaard(6), Fiona P. Havers(5), Mark W. Tenforde(5)